Terns Pharmaceuticals, Inc. (TERN)
48.44
-0.62
(-1.26%)
USD |
NASDAQ |
Mar 20, 16:00
48.50
+0.06
(+0.12%)
Pre-Market: 08:55
Terns Pharmaceuticals EPS Diluted (Quarterly) : -0.2686 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -0.6934 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| ADMA Biologics, Inc. | 0.2025 |
| Arcellx, Inc. | -1.003 |
| Corcept Therapeutics, Inc. | 0.1994 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.64M |
| Total Expenses (Quarterly) | 24.64M |
| Enterprise Value | 4.069B |
| Earnings Yield | -2.13% |
| Normalized Earnings Yield | -2.130 |